The challenge of new drug discovery for tuberculosis.
Koul, Anil; Arnoult, Eric; Lounis, Nacer; Guillemont, Jerome; Andries, Koen.
; 469(7331): 483-90, 2011 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-21270886
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.
A Receptor on Acid.
Neutralizing the HIV reservoir.
L-carnitine for cognitive enhancement in people without cognitive impairment.
Opponent and bidirectional control of movement velocity in the basal ganglia.
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis.
Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.
Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.
Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
Resistencia a Medicamentos en Mycobacterium tuberculosis: contribución de mecanismos constitutivos y adquiridos.